Amanda Mathis

1.2k total citations
24 papers, 886 citations indexed

About

Amanda Mathis is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Amanda Mathis has authored 24 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Amanda Mathis's work include Viral Infections and Vectors (6 papers), Viral Infections and Outbreaks Research (5 papers) and Mosquito-borne diseases and control (5 papers). Amanda Mathis is often cited by papers focused on Viral Infections and Vectors (6 papers), Viral Infections and Outbreaks Research (5 papers) and Mosquito-borne diseases and control (5 papers). Amanda Mathis collaborates with scholars based in United States, United Kingdom and Switzerland. Amanda Mathis's co-authors include James Edwin Hall, W. David Wilson, Farial A. Tanious, David W. Boykin, Denise S. Tevis, Chad E. Stephens, Binh Nguyen, David W. Boykin, Ray Taylor and Mohamed A. Ismail and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Amanda Mathis

23 papers receiving 860 citations

Peers

Amanda Mathis
Jean Bernatchez United States
Krzysztof Felczak United States
Fabio Zuccotto United Kingdom
Iain D. Kerr United States
Anne Goh Singapore
Manoj Munde United States
Frank Preugschat United States
Joseph H. Chan United States
Marjorie Maynadier France
Emanuela Nizi Italy
Jean Bernatchez United States
Amanda Mathis
Citations per year, relative to Amanda Mathis Amanda Mathis (= 1×) peers Jean Bernatchez

Countries citing papers authored by Amanda Mathis

Since Specialization
Citations

This map shows the geographic impact of Amanda Mathis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Mathis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Mathis more than expected).

Fields of papers citing papers by Amanda Mathis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Mathis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Mathis. The network helps show where Amanda Mathis may publish in the future.

Co-authorship network of co-authors of Amanda Mathis

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Mathis. A scholar is included among the top collaborators of Amanda Mathis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Mathis. Amanda Mathis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mathis, Amanda, et al.. (2022). Population pharmacokinetic modeling and simulations of berotralstat for prophylactic treatment of attacks of hereditary angioedema. Clinical and Translational Science. 15(4). 1027–1035. 5 indexed citations
3.
Mathis, Amanda, David Collins, Sylvia Dobo, et al.. (2022). Pharmacokinetics and Safety of the Nucleoside Analog Antiviral Drug Galidesivir Administered to Healthy Adult Subjects. Clinical Pharmacology in Drug Development. 11(4). 467–474. 10 indexed citations
4.
Julander, Justin G., James F. Demarest, Ray Taylor, et al.. (2021). An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral. Antiviral Research. 195. 105180–105180. 53 indexed citations
5.
Taylor, Ray, Richard A. Bowen, James F. Demarest, et al.. (2021). Activity of Galidesivir in a Hamster Model of SARS-CoV-2. Viruses. 14(1). 8–8. 14 indexed citations
6.
Lim, So‐Yon, Christa E. Osuna, Katharine Best, et al.. (2020). A direct-acting antiviral drug abrogates viremia in Zika virus–infected rhesus macaques. Science Translational Medicine. 12(547). 20 indexed citations
7.
Mathis, Amanda, Stuart Mair, Diane Gesty‐Palmer, et al.. (2020). BCX9930, an Oral Factor D Inhibitor, for the Potential Treatment of Alternative Pathway Mediated Diseases: Interim Results of a Phase 1 Study in Healthy Subjects. Blood. 136(Supplement 1). 15–16. 3 indexed citations
8.
Perić, Mihaela, Sulejman Alihodžić, Esperanza Herreros, et al.. (2020). A novel class of fast‐acting antimalarial agents: Substituted 15‐membered azalides. British Journal of Pharmacology. 178(2). 363–377. 9 indexed citations
9.
Chong, Pek Y., J. Brad Shotwell, John F. Miller, et al.. (2019). Design of N -Benzoxaborole Benzofuran GSK8175—Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor. Journal of Medicinal Chemistry. 62(7). 3254–3267. 45 indexed citations
10.
Westover, Jonna B., Amanda Mathis, Ray Taylor, et al.. (2018). Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters. Antiviral Research. 156. 38–45. 54 indexed citations
11.
Warren, Travis K., et al.. (2017). Efficacy of Galidesivir against Ebola Virus Disease in Rhesus Monkeys. Open Forum Infectious Diseases. 4(suppl_1). S302–S302. 10 indexed citations
12.
Vanchiere, John A., James T. Peterson, Priyesh Mehta, et al.. (2017). Single Dose IV Peramivir is Safe and Effective in the Treatment of Pediatric Influenza. Open Forum Infectious Diseases. 4(suppl_1). S694–S694. 2 indexed citations
13.
Shotwell, J. Brad, Scott H. Dickerson, Octerloney B. McDonald, et al.. (2013). Discovery of Selective Small Molecule Type III Phosphatidylinositol 4-Kinase Alpha (PI4KIIIα) Inhibitors as Anti Hepatitis C (HCV) Agents. Journal of Medicinal Chemistry. 57(5). 2091–2106. 56 indexed citations
14.
Miller, John F., et al.. (2013). Imidazopyridazine Hepatitis C Virus Polymerase Inhibitors. Structure–Activity Relationship Studies and the Discovery of a Novel, Traceless Prodrug Mechanism. Journal of Medicinal Chemistry. 57(5). 1964–1975. 9 indexed citations
15.
Chong, Pek Y., Paul R. Sebahar, Dulce Garrido, et al.. (2012). Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase. Journal of Medicinal Chemistry. 55(23). 10601–10609. 43 indexed citations
16.
Wilson, W. David, Farial A. Tanious, Amanda Mathis, et al.. (2008). Antiparasitic compounds that target DNA. Biochimie. 90(7). 999–1014. 180 indexed citations
17.
Mathis, Amanda, Arlene S. Bridges, Mohamed A. Ismail, et al.. (2007). Diphenyl Furans and Aza Analogs: Effects of Structural Modification on In Vitro Activity, DNA Binding, and Accumulation and Distribution in Trypanosomes. Antimicrobial Agents and Chemotherapy. 51(8). 2801–2810. 64 indexed citations
18.
Mathis, Amanda, et al.. (2006). Accumulation and Intracellular Distribution of Antitrypanosomal Diamidine Compounds DB75 and DB820 in African Trypanosomes. Antimicrobial Agents and Chemotherapy. 50(6). 2185–2191. 102 indexed citations
19.
Wilson, W. David, Binh Nguyen, Farial A. Tanious, et al.. (2005). Dications That Target the DNA Minor Groove: Compound Design and Preparation, DNA Interactions, Cellular Distribution and Biological Activity. PubMed. 5(4). 389–408. 152 indexed citations
20.
Duvvuri, Muralikrishna, et al.. (2004). A Cell Fractionation Approach for the Quantitative Analysis of Subcellular Drug Disposition. Pharmaceutical Research. 21(1). 26–32. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Bernatchez Breakdown of academic impact, for papers by Krzysztof Felczak Breakdown of academic impact, for papers by Fabio Zuccotto Breakdown of academic impact, for papers by Iain D. Kerr Breakdown of academic impact, for papers by Anne Goh Breakdown of academic impact, for papers by Manoj Munde Breakdown of academic impact, for papers by Frank Preugschat Breakdown of academic impact, for papers by Joseph H. Chan Breakdown of academic impact, for papers by Marjorie Maynadier Breakdown of academic impact, for papers by Emanuela Nizi
Rankless by CCL
2026